Financials
Income statement
| Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
|---|---|---|---|---|
| Total reported revenue | 55.3B | 62.2B | 59.0B | 59.6B |
| Cost of revenue | 28.2B | 28.3B | 28.9B | 26.0B |
| Gross profit | 27.2B | 33.9B | 30.1B | 33.6B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 21.0B | 29.3B | 21.7B | 26.4B |
| Other operating expenses | — | — | — | — |
| Operating income | 1.3B | 4.6B | 3.6B | 7.1B |
| Non operating interest income | ||||
| Income | — | 200M | — | — |
| Expense | — | 740M | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 762M | 4.1B | 3.1B | 6.7B |
| Tax provision | 183M | 1.0B | 778M | 1.7B |
| Net income | 579M | 3.1B | 2.3B | 5.0B |
| Basic EPS | 0.4 | 1.9 | 1.4 | 3.1 |
| Diluted EPS | 0.4 | 1.9 | 1.4 | 3.1 |
| Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
| Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
| EBITDA | 6.9B | 10.8B | 9.1B | 12.6B |
| Net income from continuing op. | 762M | 4.1B | 3.1B | 6.7B |
| Minority interests | 11M | 4M | 12M | 13M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |